StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.86+0.12 (+6.90%)

Close on Nov 20, 2026Market cap $23.33MP/E –Yield –

Incannex Healthcare free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Incannex Healthcare's free cash flow for the twelve months ending Sep 30, 2026 was -$3.19M. For fiscal 2026 it was -$12.88M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$12.88M–
FY2025Jun 30, 2025-$12.52M–
FY2024Jun 30, 2024-$16.12M–
FY2023Jun 30, 2023-$11.07M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$521.00K–
Q4 FY2026CQ2 2026Jun 30, 2026$3.38M–
Q3 FY2026CQ1 2026Mar 31, 2026-$2.46M–
Q2 FY2026CQ4 2025Dec 31, 2025-$4.63M–
Q1 FY2026CQ3 2025Sep 30, 2025-$9.17M–
Q4 FY2025CQ2 2025Jun 30, 2025-$1.48M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.16M–
Q4 FY2024CQ2 2024Jun 30, 2024-$3.65M–
Q3 FY2024CQ1 2024Mar 31, 2024-$4.35M–
Q2 FY2024CQ4 2023Dec 31, 2023-$2.16M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.97M–
Q4 FY2023CQ2 2023Jun 30, 2023-$2.75M–
Q3 FY2023CQ1 2023Mar 31, 2023-$2.76M–

More Incannex Healthcare figures

See a number that looks wrong?